Cargando…

Recently published papers: predictors, pressors and poietins

Simple, sensitive and specific predictors of mortality in the critically ill remain elusive goals, and brain natriuretic peptide and venous lactate are the subjects of recent studies. The role of vasopressin in sepsis continues to be the focus of much research interest. Dose ranging studies, potenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, Suzannah, Venn, Richard
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246219/
https://www.ncbi.nlm.nih.gov/pubmed/18190727
http://dx.doi.org/10.1186/cc6188
_version_ 1782150743320428544
author Ward, Suzannah
Venn, Richard
author_facet Ward, Suzannah
Venn, Richard
author_sort Ward, Suzannah
collection PubMed
description Simple, sensitive and specific predictors of mortality in the critically ill remain elusive goals, and brain natriuretic peptide and venous lactate are the subjects of recent studies. The role of vasopressin in sepsis continues to be the focus of much research interest. Dose ranging studies, potential adverse effects, and selective V1 agonists are discussed below in recent trials. Finally the use of erythropoietin in the critically ill continues to be studied but many continue to urge caution for widespread use outside of clinical trials.
format Text
id pubmed-2246219
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22462192008-02-20 Recently published papers: predictors, pressors and poietins Ward, Suzannah Venn, Richard Crit Care Commentary Simple, sensitive and specific predictors of mortality in the critically ill remain elusive goals, and brain natriuretic peptide and venous lactate are the subjects of recent studies. The role of vasopressin in sepsis continues to be the focus of much research interest. Dose ranging studies, potential adverse effects, and selective V1 agonists are discussed below in recent trials. Finally the use of erythropoietin in the critically ill continues to be studied but many continue to urge caution for widespread use outside of clinical trials. BioMed Central 2007 2007-12-21 /pmc/articles/PMC2246219/ /pubmed/18190727 http://dx.doi.org/10.1186/cc6188 Text en Copyright © 2007 BioMed Central Ltd
spellingShingle Commentary
Ward, Suzannah
Venn, Richard
Recently published papers: predictors, pressors and poietins
title Recently published papers: predictors, pressors and poietins
title_full Recently published papers: predictors, pressors and poietins
title_fullStr Recently published papers: predictors, pressors and poietins
title_full_unstemmed Recently published papers: predictors, pressors and poietins
title_short Recently published papers: predictors, pressors and poietins
title_sort recently published papers: predictors, pressors and poietins
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246219/
https://www.ncbi.nlm.nih.gov/pubmed/18190727
http://dx.doi.org/10.1186/cc6188
work_keys_str_mv AT wardsuzannah recentlypublishedpaperspredictorspressorsandpoietins
AT vennrichard recentlypublishedpaperspredictorspressorsandpoietins